Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

DOI Full Paper Access

75

Citations

31

References

2018

Year

Thomas J. Ettrich, Andreas W. Berger, Lukas Perkhofer, S Daum, Alexander König, Andreas Dickhut, Uwe A. Wittel, Kai Wille, Hana Algül, Eike Gallmeier,

References

	Year	Citations

Page 1